Literature DB >> 27298230

Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head: a meta-analysis.

Francesco Sadile1, Alessio Bernasconi1, Sergio Russo1, Nicola Maffulli2.   

Abstract

INTRODUCTION: Osteonecrosis of femoral head (ONFH) leads to hip osteoarthritis (HOA); among joint preserving treatments (JPT), the role of core decompression (CD) is still debated. We assessed the efficacy of CD compared with all other JPT in delaying the natural osteonecrosis evolution to HOA. SOURCES OF DATA: Following the PRISMA checklist, the Medline and Scopus databases were searched. Fifteen- to 70-year-old subjects with ONFH with a minimum follow-up of 24 months were considered. The outcomes evaluated were patient clinical status, radiographic progression and total hip arthroplasty (THA) or further surgery (FS) need. Risk ratio (RR) was calculated for every outcome reported. RCT, CCT and prospective studies were included. AREAS OF AGREEMENT: A total of 12 studies (776 patients) met the inclusion criteria. Clinical outcome (RR = 1.14; 95% CI 0.58-2.32; P = 0.05), radiographic progression (RR = 1.64; 95% CI 1.14-2.35; P = 0.05) and the need for THA/FS (RR = 1.52; 95% CI 0.95-2.45; P = 0.05) suggested a slight superiority of other JPT compared with CD. AREAS OF CONTROVERSY: High heterogeneity of the primary investigations was the main limitation of our study. GROWING POINTS: The efficacy and effectiveness of core decompression for ONFH are, at best, no better than other joint preserving strategies. The more recent scientific evidence seems to suggest that such procedure is less successful than other joint preserving strategies. AREAS TIMELY FOR DEVELOPING RESEARCH: Further studies are needed to identify the best therapeutic approach to the ONFH.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  core decompression; femoral head; hip osteoarthritis; joint preserving treatments; osteonecrosis

Mesh:

Year:  2016        PMID: 27298230      PMCID: PMC5127418          DOI: 10.1093/bmb/ldw010

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  41 in total

1.  Core decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysis.

Authors:  F P Castro; R L Barrack
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2000-03

2.  Transtrochanteric anterior rotational osteotomy for idiopathic and steroid-induced necrosis of the femoral head. Indications and long-term results.

Authors:  Y Sugioka; T Hotokebuchi; H Tsutsui
Journal:  Clin Orthop Relat Res       Date:  1992-04       Impact factor: 4.176

3.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors:  S H Downs; N Black
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

4.  Core decompression for osteonecrosis of the femoral head.

Authors:  D C Markel; C Miskovsky; T P Sculco; P M Pellicci; E A Salvati
Journal:  Clin Orthop Relat Res       Date:  1996-02       Impact factor: 4.176

5.  Are the results of multiple drilling and alendronate for osteonecrosis of the femoral head better than those of multiple drilling? A pilot study.

Authors:  Pengde Kang; Fuxing Pei; Bin Shen; Zongke Zhou; Jing Yang
Journal:  Joint Bone Spine       Date:  2011-07-13       Impact factor: 4.929

Review 6.  Core decompression of the osteonecrotic femoral head.

Authors:  S W Smith; T K Fehring; W L Griffin; W B Beaver
Journal:  J Bone Joint Surg Am       Date:  1995-05       Impact factor: 5.284

Review 7.  Osteonecrosis of the femoral head: evaluation and treatment.

Authors:  Charalampos G Zalavras; Jay R Lieberman
Journal:  J Am Acad Orthop Surg       Date:  2014-07       Impact factor: 3.020

Review 8.  Core decompression versus nonoperative management for osteonecrosis of the hip.

Authors:  M A Mont; J J Carbone; A C Fairbank
Journal:  Clin Orthop Relat Res       Date:  1996-03       Impact factor: 4.176

Review 9.  Do modern techniques improve core decompression outcomes for hip osteonecrosis?

Authors:  David R Marker; Thorsten M Seyler; Slif D Ulrich; Siddharth Srivastava; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2008-04-08       Impact factor: 4.176

10.  Vascularized fibular grafting compared with core decompression in the treatment of femoral head osteonecrosis.

Authors:  S M Kane; W A Ward; L C Jordan; W B Guilford; E N Hanley
Journal:  Orthopedics       Date:  1996-10       Impact factor: 1.390

View more
  26 in total

1.  No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis.

Authors:  Byung-Ho Yoon; Young-Kyun Lee; Ki-Choul Kim; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  Int Orthop       Date:  2018-05-31       Impact factor: 3.075

2.  CORR Insights®: Free Vascularized Fibular Grafting Improves Vascularity Compared With Core Decompression in Femoral Head Osteonecrosis: A Randomized Clinical Trial.

Authors:  Anton Plakseychuk
Journal:  Clin Orthop Relat Res       Date:  2017-06-22       Impact factor: 4.176

3.  CORR Insights®: Did Osteoblastic Cell Therapy Improve the Prognosis of Pre-fracture Osteonecrosis of the Femoral Head? A Randomized Controlled Trial.

Authors:  Geert Meermans
Journal:  Clin Orthop Relat Res       Date:  2020-06       Impact factor: 4.755

4.  Platelet-rich plasma has beneficial effects in mice with osteonecrosis of the femoral head by promoting angiogenesis.

Authors:  Shichao Tong; Jimin Yin; Ji Liu
Journal:  Exp Ther Med       Date:  2017-12-18       Impact factor: 2.447

5.  eIF2α signaling regulates ischemic osteonecrosis through endoplasmic reticulum stress.

Authors:  Daquan Liu; Yunlong Zhang; Xinle Li; Jie Li; Shuang Yang; Xiaoxue Xing; Guanwei Fan; Hiroki Yokota; Ping Zhang
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

6.  Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy.

Authors:  Michael Ian Jarman; Kevin Lee; Ariel Kanevsky; Sarah Min; Ilana Schlam; Chris Mahida; Ali Huda; Alexander Milgrom; Naila Goldenberg; Charles J Glueck; Ping Wang
Journal:  BMC Hematol       Date:  2017-03-27

7.  Use of autologous bone marrow stem cell implantation for osteonecrosis of the knee in sickle cell disease: a preliminary report.

Authors:  Gildasio Daltro; Bruno Adelmo Franco; Thiago Batista Faleiro; Davi Araujo Veiga Rosário; Paula Braga Daltro; Roberto Meyer; Vitor Fortuna
Journal:  BMC Musculoskelet Disord       Date:  2018-05-22       Impact factor: 2.362

8.  Bone morphogenetic protein-2 exhibits therapeutic benefits for osteonecrosis of the femoral head through induction of cartilage and bone cells.

Authors:  Chunhui Wang; Huimei Zang; Dongsheng Zhou
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

9.  High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head.

Authors:  Kai Xie; Yuanqing Mao; Xinhua Qu; Kerong Dai; Qingwei Jia; Zhenan Zhu; Mengning Yan
Journal:  J Orthop Surg Res       Date:  2018-02-02       Impact factor: 2.359

10.  Biomechanical effect of intertrochanteric curved varus osteotomy on stress reduction in femoral head osteonecrosis: a finite element analysis.

Authors:  Yuzhu Wang; Go Yamako; Takato Okada; Hideki Arakawa; Yoshihiro Nakamura; Etsuo Chosa
Journal:  J Orthop Surg Res       Date:  2021-07-23       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.